Bill Detail
S. 1302
Congress: 119
Title
Increasing Transparency in Generic Drug Applications Act
Summary
No summary published on Congress.gov yet — common for recently introduced bills.
Sponsor
Sen. Maggie Hassan [D-NH]
Status
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Status as of Jun 29, 4:14 AM · synced 16h ago
Introduced
2025-04-03
Data source mode: cache
Bill Engagement
Increasing Transparency in Generic Drug Applications Act
Sponsor
Sen. Maggie Hassan [D-NH]D
Status
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Cosponsors
2D · 4R
Bipartisan
LDA engagement
3 orgs · 4 filings
Top: Biotechnology Innovation Organization
Introduced
2025-04-03
Lobbyists on the case
3 orgs · 42 lobbyists · 4 filings mention S. 1302 (Increasing Transparency in Generic Drug Applications Act) in LDA disclosures.
Top orgs filing
- Biotechnology Innovation Organization2 filings · 12 lobs
- Pharmaceutical Research and Manufacturers of America1 filing · 24 lobs
- Blue Cross and Blue Shield Association1 filing · 6 lobs
Lobbyists on this bill
- Emily Acker2026 Q1
- Phyllis Arthur2026 Q1
- Elisabeth Fox2026 Q1
- Aiken Hackett2026 Q1
- Praneel Jadav2026 Q1
- Chris Jones2026 Q1
- David Lachmann2026 Q1
- Amber Manko2026 Q1
+ 34 more